• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS PROLACTIN ASSAY; RADIOIMMUNOASSAY, PROLACTIN (LACTOGEN)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS PROLACTIN ASSAY; RADIOIMMUNOASSAY, PROLACTIN (LACTOGEN) Back to Search Results
Catalog Number 07027737190
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/04/2021
Event Type  malfunction  
Manufacturer Narrative
Unique identifier (udi) # (b)(4).(b)(6).This event occurred in (b)(6).The investigation is ongoing.
 
Event Description
The initial reporter received questionable elecsys prolactin assay results with 23 patient samples on a 8000 e 801 module, serial number (b)(4).Refer to attachment "(b)(6)" for patient results.The roche results were questioned as they were incompatible with the patients' clinical picture and repeat testing by the siemens centaur method was performed.
 
Manufacturer Narrative
Calibration and qc were within specifications.The customer correctly pretreated the samples with peg (polyethylene glycol) prior to testing.Testing results: (listed as: patient id: prl ii+peg (ng/ml), prl ii/c, peg/c).2: 33, 149%, 112%.3: 32, 143%,119%.4: 37.8, 172%, 147%.5: 28.2, 136%, 107%.6: 33.4, 139%, 121%.7: 26.6, 150%, 121%.8: 38.4, 141%, 139%.9: 24.8, 152%, 119%.14: 19.76, 132%, 101%.15: 22.4, 133%, 114%.17: 19.36, 154%, 127%.18: 29.4, 178%, 154%.19: 22, 131%, 100%.20: 31.8, 147%, 123%.21: 27, 131%, 76%.22: 40.6, 139%, 96%.23: 18.3, 146%, 90%.24: 27.2, 173%, 145%.26: 57.4, 144%, 121%.27: 25.2, 141%, 129%.29: 17.48, 144%, 107%.31: 19.32, 151%, 131%.32: 15.14, 172%, 123%.The investigation found that the samples are suspicious of containing high amounts of macro prolactin, for which the elecsys prl ii assay is more sensitive than the centaur/seimens platform.The customer pre-selected special patient samples and compared those to a competitor assay.This is suggested by high frequency of > reference range samples with low post-peg prl ii recovery the investigation concluded the measured values are correct.The investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS PROLACTIN ASSAY
Type of Device
RADIOIMMUNOASSAY, PROLACTIN (LACTOGEN)
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key11388436
MDR Text Key254710418
Report Number1823260-2021-00602
Device Sequence Number1
Product Code CFT
Combination Product (y/n)N
PMA/PMN Number
K964748
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 05/04/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/26/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2021
Device Catalogue Number07027737190
Device Lot Number48264802
Was Device Available for Evaluation? Yes
Date Manufacturer Received02/04/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-